Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- A. Lonardo, F. Nascimbeni, A. Mantovani, G. Targher
- BiologyJournal of Hepatology
- 1 February 2018
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- A. Mantovani, C. Byrne, E. Bonora, G. Targher
- MedicineDiabetes Care
- 12 January 2018
NAFLD is significantly associated with a twofold increased risk of incident diabetes, however, the observational design of the eligible studies does not allow for proving causality.
Indocyanine green angiography in Vogt–Koyanagi–Harada disease: angiographic signs and utility in patient follow-up
- C. Herbort, A. Mantovani, N. Bouchenaki
- MedicineInternational ophtalmology
- 25 April 2007
Choroidal inflammation shown by ICG angiography can be suppressed completely by initial high-dose inflammation suppressive therapy, however, recurrent subclinical choroidalinflammatory activity is detected at the end of the tapering period in a high proportion of cases.
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
- A. Mantovani, G. Zaza, G. Targher
- MedicineMetabolism: Clinical and Experimental
- 1 February 2018
Complications, morbidity and mortality of nonalcoholic fatty liver disease.
- A. Mantovani, E. Scorletti, A. Mosca, A. Alisi, C. Byrne, G. Targher
- MedicineMetabolism: Clinical and Experimental
- 29 January 2020
Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
- A. Mantovani, C. Byrne, M. Zheng, G. Targher
- MedicineNMCD. Nutrition Metabolism and Cardiovascular…
- 29 May 2020
Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
- A. Mantovani, F. Nascimbeni, G. Targher
- Medicine, BiologyThyroid
- 18 September 2018
A large and updated meta-analysis of relevant studies shows that the presence of variably defined hypothyroidism is significantly associated with the presence and severity of NAFLD.
Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
- A. Mantovani, P. Gisondi, A. Lonardo, G. Targher
- Biology, MedicineInternational Journal of Molecular Sciences
- 1 February 2016
The rapidly expanding body of clinical and epidemiological evidence supporting a strong association between nonalcoholic fatty liver disease and chronic plaque psoriasis is discussed, and the published evidence argues for more careful evaluation and surveillance of NAFLD among patients with Psoriasis.
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
- G. Targher, A. Mantovani, M. Zheng
- MedicineGut
- 14 May 2020
Patients with MAFLD with increased non-invasive liver fibrosis scores are at higher risk of severe illness from COVID-19, according to the originally validated cut-points for fibrosis-4 (FIB-4) index and NAFLD fibrosis score (NFS).
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
- A. Mantovani, Giorgia Beatrice, A. Dalbeni
- MedicineLiver international (Print)
- 4 April 2020
The overall prevalence of chronic liver disease among patients with COVID‐19 disease was 3% and individuals with severe COVID-19 disease had relevant alterations of liver enzymes and coagulative profile, probably due to the innate immune response against the virus.
...
...